Loading clinical trials...
Loading clinical trials...
Study to evaluate the performance of the AggreGuide A-100 ADP assay for detection of platelet dysfunction caused by P2Y12 inhibitor antiplatelet therapy.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Aggredyne, Inc.
NCT05708807 · Stroke, Stroke Hemorrhagic, and more
NCT04840030 · Dementia, Cognitive Decline, and more
NCT03436238 · Perioperative/Postoperative Complications, Risk Factor, Cardiovascular
NCT04026737 · Leukemia, Lymphoma, and more
NCT04023110 · Cardiotoxicity, Risk Factor, Cardiovascular, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions